A comprehensive view of Diabetes. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

US Patent Issued to Pfizer on April 23 for "Heteroaromatic compounds and their use as dopamine D1 ligands" (Massachusetts, Connecticut, Colorado Inventors)
Published: April 24, 2024 by U.S. Fed News
Researchers Submit Patent Application, 'Hard Seal Compact, Positive Displacement Pump With Reciprocating Motion', for Approval (USPTO 20240110551)
Published: April 24, 2024 by Health & Medicine Business Daily
Medtronic's MiniMed 780G system, a therapy for type 1 diabetes, could generate cost savings for healthcare systems, according to recent studies in Europe and Singapore; the system was found to be more cost-effective than standard treatments
Published: April 23, 2024 by U.S. Markets (Alternative Disclosure) via PUBT
American Diabetes Assn. applauds New York’s move to eliminate cost-sharing for insulin in state-regulated health plans, marking a significant step towards medication affordability; nearly 12% of adult population in NY have been diagnosed with diabetes
Published: April 22, 2024 by American Diabetes Association
U.S. Patent and Trademark Office Releases Pfizer Inc's Patent Application for Pyrido[2,3-D]Imidazole Derivatives and Their Use as Inhibitors of ITK for the Treatment of Skin Disease
Published: April 22, 2024 by Pharmaceutical Patent News

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count